InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,520.27
(
0.20%
)
US TECH 100
19,578.80
(
0.51%
)
Dow Jones
39,265.35
(
-0.17%
)
Brent Oil
85.99
(
-0.53%
)
Bitcoin
60,334.90
(
-2.73%
)
Post# of 13959
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Mikefbi

Send PM Follow Ignore
Followers 1
Posts 426
Boards Moderated 0
Alias Born 06/10/2018

Mikefbi

Re: Letterpenny post# 13356

Monday, 01/01/2024 7:57:31 PM

Monday, January 01, 2024 7:57:31 PM

Post# of 13959
Hilarious
Immune Pharmaceuticals has absolutely no interest in Ceplene.
Once the sale of Ceplene and Bertilimumab took place it was all over for Immune Pharmaceuticals shareholders.

Letterpenny Your statement about Ceplene
licensing agreements again no value to shareholders of Immune Pharmaceutical Ceplene sold to Discover in 2020
Cuckoo Penny
Check your facts and dates.
Don't let smoke get in your eyes.

Hehe
Cheers

Happy New Years
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up